Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Multiple Myeloma 3Lymphoma 3Melanoma 2Lung Neoplasms 2Hematologic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Skin Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1NSCLC Harboring NRG1 Fusion 1Mouth Neoplasms 1Glioma 1Fanconi Anemia 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 11pembrolizumab 10Carboplatin 7Radiotherapy 6Cetuximab 6Docetaxel 5Surveys and Questionnaires 3Radiotherapy, Intensity-Modulated 3Paclitaxel 3Cyclophosphamide 3fludarabine 2cemiplimab 2atezolizumab 2aldesleukin 2Surgical Procedures, Operative 2Standard of Care 2Radiation 2Nivolumab 2Magnetic Resonance Spectroscopy 2Fluorouracil 2Drug Therapy 2vistusertib 1toripalimab 1sitravatinib 1palbociclib 1osimertinib 1olaparib 1niraparib 1lenvatinib 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Afatinib × 90 days × Clear all
NCT05070403 2026-04-01

Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Recruiting
25 enrolled
Dermatologic

Carcinoma, Squamous Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡